PRESS RELEASE 9th August, 2022 Imspex Diagnostics announces BreathSpec® Instrument Receives CE Mark for Covid-19 testing Abercynon, Wales, UK – Imspex Diagnostics Ltd today announced that it has received CE mark for its BreathSpec® instrument for the detection of COVID-19 using non-invasive breath testing and analysis having met the requirements of the European In-Vitro Diagnostics […]

Don’t sweat it, we can test it!

Besides sometimes giving off an unpleasant odour, there are many things that sweat can tell us about the human body.
The main function of sweat is to control your body temperature.

The perfect pint and how to achieve it

There are many elements to delivering the perfect pint. Whether it’s from the very beginning in the brewing process or right through to pouring it into the most perfectly formed glass.

Testing origins. Is it really Champagne?

Do you get your kicks from Champagne? Then you might be interested to know that Champagne producers test the quality of their product to ensure their grapes are actually from the region. You don’t want to find out that your expensive bottle of plonk is actually a cheap version of the real McCoy!

Co-Vid 19 Resilience Innovation success

Imspex Diagnostics was successful in its recent SMARTCymru application for funding to further establish its BreathSpec® technology’s potential as a channel to boost economic recovery as we emerge from the COVID-19 pandemic. The SMARTCymru-European Regional Development Fund (ERDF) funding will be used to further validate BreathSpec®’s capability for rapid detection of COVID-19 in clinical settings […]

Moving the momentum forward with Imspex Medical

From the beginning, Imspex Diagnostic’s ambition has been to bring the unique advantages of GC-IMS technology to patients. Our aim has always been to give patients the best possible chance to beat disease conditions by detecting and diagnosing these as early as possible. Our journey to being able to do so is continuing apace. A […]

Setting the standard for siloxane measurement in biomethane testing

Imspex Diagnostics recently partnered with the National Physical Laboratory (NPL), @KTNUK and @InnovateUK in their Analysis for Innovators (A4i) programme to investigate the utility of our GC-IMS technology combination for detecting and quantifying siloxanes from biomethane. This is an important collaboration, both from environmental and analytical method development perspectives. NPL will now propose GC-IMS as […]

Emerging Tech Fest 2021

Michael Graz, CEO of Imspex Medical, shared the stage with Phil Groom, Commercial Director (Global) of Bond Digital Health, at the Emerging Tech Fest on 28 January 2021 to showcase a Welsh opportunity to create a secure Digital Health Passport as a way of unlocking economic activity.  This talk presented a scalable and imminently accessible […]